Unilateral injection of botulinum toxin in blepharospasm: Single fiber electromyography and blink reflex study

Movement Disorders

Volumn 11, Issue 1, 1996, Pages 27-31

  Girlanda, P ^a,b   Quartarone, A ^a   Sinicropi, S ^a   Nicolosi, C ^a   Messina, C ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Blepharospasm; Blink reflex; Botulinum toxin; Single fiber electromyography

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; EXCITABILITY; EYELID REFLEX; FACIAL NERVE; FEMALE; HUMAN; MALE; MUSCLE ACTION POTENTIAL; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; ORBICULARIS OCULI MUSCLE; PRIORITY JOURNAL; TIME;

AGED; BLEPHAROSPASM; BLINKING; BOTULINUM TOXINS; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROMUSCULAR JUNCTION; SYNAPTIC TRANSMISSION;

EID: 0030025541     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110107     Document Type: Article

References (20)

1. Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1990;40:1332-1336.
2. NIH Consensus Development Conference Consensus Statement. Clinical use of botulinum toxin. NIH Consensus Development Conference, Vol. 8, No. 8. November 12-14, 1990.
3. Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology. Ophthalmology 1989;2:37-41.
4. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194.
5. Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992;359:832-835.
6. Mikhailov VV. Electrophysiological analysis of disturbances in reflex activity of the spinal cord in experimental botulism. Bull Exp Biol Med 1958;46:1188-1192.
7. Williams RS, Tse CK, Dolly JO, Hambleton P, Melling J. Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes. Eur J Biochem 1983;131:437-445.
8. 125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn Schmiedebergs Arch Pharmacol 1974;281:47-56.
9. Hagenah R, Benecke R, Wiegand H. Effects of type A botulinum toxin on the cholinergic transmission at spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurones. Naunyn Schmiedebergs Arch Pharmacol 1977; 299:267-272.
10. Berardelli A, Rothwell JC, Day BL, Marsden CD. Pathophysiology of blepharospasm and oromandibular dystonia. Brain 1985;108:593-608.
11. Tolosa ES, Monserrat L, Bayes A. Blink-reflex in focal dystonias. Mov Disord 1988;3:61-69.
12. Fahn S, List T, Moskowitz T, et al. Double-blind controlled study of botulinum toxin for blepharospasm. Neurology 1985;35:271-272.
13. Brin MF, Fahn S, Moskowitz T, et al. Localised injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987;2:237-254.
14. Elston JS. The clinical use of botulinum toxin. Semin Ophthalmol 1988;4:249-260.
15. Valls-Sole J, Tolosa ES, Ribera G. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospas J Neurol Neurosurg Psychiatry 1991;54:310-313.
16. Cohen LG, Hallet M, Warden M, Dambrosia J. Excitability of blink reflexes in patients with blepharospasm after successful treatment with botulinum toxin. Ann Neurol 1987; 22:172.
17. Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: a double blind, placebo-controlled study. Neurology 1987:37:616-623.
18. Kimura J. Disorder of interneurons in parkinsonism. The orbicularis oculi reflex to paired stimuli. Brain 1973;96:87-96.
19. Girlanda P, Vita G, Nicolosi C, Milone M, Messina C. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 1992;55:844-845.
20. Lange DI, Brin MF, Warner CI, Fahn S, Lovelace RE. Distant effects of local injection of botulinum toxin. Muscle Nerve 1987;10:552-555.